13 October 2025
New prescription-strength pain relief hits high street chemists, hailed as ‘game-changer’ by pharmacists
Alderley Park, Cheshire, UK – A new anti-inflammatory pain relief treatment available from pharmacies, is being described as a ‘game-changer’ for the millions of people who suffer short-term back, muscle and joint pain every year in the UK. … Naprosyn® Pain Relief is the first...
16 September 2025
Pencil Biosciences appoints Jonathan Thon, PhD, as Chair of the Board of Directors
Cheshire, UK – September 15, 2025 – Pencil Biosciences, a biotech company pioneering a new class of gene editor, today announced the appointment of Jonathan Thon, PhD, as the new Chair of its Board of Directors. The company’s novel platform, which offers “break-free editing” and...
15 September 2025
The Biorenewables Development Centre partners with CroBio on Engineering Biology Award to tackle water scarcity
The Biorenewables Development Centre (BDC) and UK-based biotech company CroBio have secured an Engineering Biology SPARK Award from InnovateUK. This funding will support a collaborative project aimed at developing a non-genetically modified (non-GM) microbial soil amendment to...
27 August 2025
AARDEX Group and Pill Connect partner to advance dose selection with real-time adherence monitoring in phase 2A clinical trial
Liège, Belgium and Manchester, UK; August 2025: AARDEX Group, a global leader in digital medication adherence solutions, and Pill Connect, a pioneer in connected dispensing technology, have announced a strategic partnership to support a multi-cohort Phase 2A dose selection...
20 August 2025
Monument Therapeutics announces partnership with Foundation for the National Institutes of Health for clinical trial of MT1988, a novel treatment for schizophrenia
MANCHESTER, England, Aug. 19, 2025 /PRNewswire/ -- Monument Therapeutics, a stratified medicine company, today announced a partnership with the Foundation for the National Institutes of Health (FNIH) to evaluate MT1988, a novel treatment in development for cognitive impairment...
19 August 2025
Marketing Authorisation Application for CT001 submitted to the European Medicines Agency for acute pain management in children
• Proveca has submitted a Paediatric Use Marketing Authorisation (PUMA) application for CT001 (ketamine/sufentanil nasal spray) to the EMA … • The validation process has been completed … • The review process will now be initiated and potential approval expected in 2026 …...
29 July 2025
Maxwellia announces three new board appointments to strengthen commercial and strategic leadership
Alderley Park, Cheshire, UK – Tuesday 29 July 2025 – Maxwellia is pleased to announce the appointments of Candice Brett as an Executive Director and Ian Adamson and John Gunn as Non-Executive Directors to the Maxwellia Board. The appointments form part of Maxwellia’s ongoing...
7 July 2025
Oxford BioTherapeutics announces third oncology drug candidate from Boehringer Ingelheim collaboration selected to advance into IND-enabling studies
• Drug candidate is one of several oncology assets approaching or in clinical development, discovered through Oxford BioTherapeutics’ proprietary OGAP®-Verify discovery platform … • OBT receives milestone payment associated with advance of drug candidate … Oxford, UK and San...
23 June 2025
Monument Therapeutics reports positive Phase I results for novel cognitive impairment in schizophrenia treatment
Manchester, UK, 23 June 2025 - Monument Therapeutics, a precision neuroscience company, today announced positive topline results from its Phase I clinical trial evaluating MT1988, a novel treatment targeting cognitive impairment associated with schizophrenia (CIAS). MT1988 is a...
21 May 2025
INFEX Therapeutics agrees collaboration with Asian clinical trials network, ADVANCE-ID
Alderley Park, Cheshire, U.K. Infex Therapeutics, a leading anti-infectives specialist, announces that it has signed a memorandum of understanding (MOU) (the “Collaboration”) with ADVANCE-ID, a clinical trials network comprising over 100 hospitals in Asia, to investigate...